Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markersVishal Navani, André van der Westhuizen, Moira C. Graves et al.|Pharmacology Research & Perspectives|2021Cited by 10
Business as unusual: medical oncology services adapt and deliver during <scp>COVID</scp>‐19Avraham Travers, James Lynam, Kim Adler et al.|Internal Medicine Journal|2021Cited by 9
CABOSEQ: The efficacy of cabozantinib post up-front immuno-oncology combinations in patients with advanced renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).Vishal Navani, Daniel Yick Chin Heng, Connor Wells et al.|Journal of Clinical Oncology|2022Cited by 5
Characterizing IMDC prognostic groups in contemporary first-line combination therapies for metastatic renal cell carcinoma (mRCC).Matthew Scott Ernst, Daniel Yick Chin Heng, Vishal Navani et al.|Journal of Clinical Oncology|2022Cited by 3
Comparison of outcomes for Hispanic and non‐Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma DatabaseKripa Guram, Rana R. McKay, Jiaming Huang et al.|Cancer|2024Cited by 3